VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

Completed · Phase 4 · Has a placebo group

Conditions studied: Infections, Herpesviridae

In brief

Eligible subjects will be randomized to receive VALTREX® tablet 1g or placebo once daily for 60 days in a two-way crossover study with a washout period of 7 days between treatment periods.

Key facts

Study ID

NCT00116844

Run by

GlaxoSmithKline

People needed

73

Starts

2005-03-29

Expected to finish

2006-01-10

Last updated by the study team

2018-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• In overall general good health.
• HSV-2 (Herpes Simplex Virus-2) seropositive at screening.

You may not qualify if…

• have active lesions consistent with genital herpes.
• previous history of symptomatic genital herpes.
• history of recurrent, undiagnosed symptoms consistent with genital herpes.

Where it is running

• GSK Investigational Site — Carmichael, California, United States
• GSK Investigational Site — Davis, California, United States
• GSK Investigational Site — Riverside, California, United States
• GSK Investigational Site — Sacramento, California, United States
• GSK Investigational Site — Fort Wayne, Indiana, United States
• GSK Investigational Site — Indianapolis, Indiana, United States
• GSK Investigational Site — Boston, Massachusetts, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — Stony Brook, New York, United States
• GSK Investigational Site — The Bronx, New York, United States
• GSK Investigational Site — Chapel Hill, North Carolina, United States
• GSK Investigational Site — Tulsa, Oklahoma, United States
• GSK Investigational Site — Portland, Oregon, United States
• GSK Investigational Site — Houston, Texas, United States
• GSK Investigational Site — Salt Lake City, Utah, United States
• GSK Investigational Site — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.